Angiotensin II Type 1 Receptor-Dependent Nuclear Factor-κB Activation-Mediated Proinflammatory Actions in a Rat Model of Obstructive Acute Pancreatitis-Reference-Cited by-同舟云学术

Angiotensin II Type 1 Receptor-Dependent Nuclear Factor-κB Activation-Mediated Proinflammatory Actions in a Rat Model of Obstructive Acute Pancreatitis

Published:2007-07-06 Issue:1 Volume:323 Page:10-18
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Chan Yuk Cheung,Leung Po Sing

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference38 articles.

1. Lipid Peroxidation Inhibition Reduces NF-κB Activation and Attenuates Cerulein-induced Pancreatitis

2. NADPH Oxidase: An Update

3. Melatonin protects against pancreaticobiliary inflammation and associated remote organ injury in rats: role of neutrophils

4. Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats

5. Angiotensin II Stimulates Matrix Metalloproteinase Secretion in Human Vascular Smooth Muscle Cells via Nuclear Factor-κB and Activator Protein 1 in a Redox-Sensitive Manner

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ellagic acid protects against angiotensin II‐induced hypertrophic responses through ROS‐mediated MAPK pathway in H9c2 cells;Environmental Toxicology;2024-02-15

2. COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events;Vaccines;2023-03-28

3. High throughput screen of small molecules as potential countermeasures to galactic cosmic radiation induced cellular dysfunction;Life Sciences in Space Research;2022-11

4. 2D MoSe2@PVP nanosheets with multi-enzyme activity alleviate the acute pancreatitis via scavenging the reactive oxygen and nitrogen species;Chemical Engineering Journal;2022-10

5. Prussian blue nanozyme-mediated nanoscavenger ameliorates acute pancreatitis via inhibiting TLRs/NF-κB signaling pathway;Theranostics;2021